Aniracetam facilitates communication within the brain, improving the speed and operation of the mind
Numerous tests have proven that Aniracetam is one of the most potent nootropics, or ‘smart drugs’, currently available. Nootropic is the term used to describe drugs that act on the mind. The term was first used by Dr. Giurgea to describe a substance that was found to have beneficial effects in the treatment of memory loss, age related memory decline and lack of concentration.
Aniracetam is an analogue of Piracetam, purported to improve memory recall, reaction and detail. Like many of Piracetam's analogues, less Aniracetam is required (milligram dose per pound of body weight). But like Piracetam, Aniracetam has been found to be virtually non-toxic, with very few side effects and contraindications. Compared to Piracetam, Aniracetam has a more potent AMPA receptor enhancing effect, resulting in better focus and concentration.
One of the primary differences between nootropics and other ‘memory enhancers’ is that nootropics improve communication across the brain's Corpus Callosum, the area of the brain that joins the left and right hemispheres. This cross-brain communication links the logical side of the brain with the creative side of the brain, allowing the user to draw on a greater potential of their mental ability.
Aniracetam is also considered to be a drug that can modulate the brain acetylcholine system. Findings show that Aniracetam administration significantly improves the cognitive function of patients with senile dementia of the Alzheimer type. The most likely explanation for this is that regular doses of Aniracetam has made a positive impact on the brain’s memory mechanism.
It also has a beneficial affect on the body as a whole, with improvements shown in users’ immune systems, increasing resistance to infection and generating a feeling of health and well-being, particularly in the elderly.